Fenfluramine

Records for this ingredient, by country (identity only).

ATC N03AX26 · 9 markets · 10 records

Fenfluramine 9 markets · 10 records Forms

Filters

MarketUS 1 GB 1 AU 1 ES 1 TW 1 HK 1 JP 1 EU 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

2.2 mg per mL / per unit basis not statedliquidFintepla

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

2.2 mg per mL / per unit basis not statedliquidFintepla 2.2mg/ml oral solution

AU 1 records · 1 shown of 1 Source PBS Schedule API v3 (Department of · Data as of 2026-10-01

2.2 mg/1 mLliquidFintepla also in ES

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

2.2 mg/1 mLliquidFintepla also in AU

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

2.2 mg per mL / per unit basis not statedliquidFintepla 2.2mg/ml oral solution+1飛癲寧口服溶液2.2毫克/毫升

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Fintepla 2.2mg/ml oral solution ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

0.22 %/1 mLotherフィンテプラ内用液2.2mg/mL

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Fintepla ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	AU	ES	TW	HK	JP	EU
2.2 mg per mL / per unit basis not stated cannot compare liquid	Fintepla	Fintepla 2.2mg/ml oral solution	not recorded	not recorded	Fintepla 2.2mg/ml oral solution 飛癲寧口服溶液2.2毫克/毫升	not recorded	not recorded	not recorded
2.2 mg/1 mL liquid	not recorded	not recorded	Fintepla	Fintepla	not recorded	not recorded	not recorded	not recorded
0.22 %/1 mL other	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	フィンテプラ内用液2.2mg/mL	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	Fintepla 2.2mg/ml oral solution	not recorded	Fintepla

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in HK · JP · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en HK · JP · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 HK · JP · EU 有记录（未在本表显示）。另有 2 個規格/劑型僅在 HK · JP · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.